| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5188 | Tol8-agonist-31a | Novel Human Toll-like Receptor 8-Selective Agonist |
|
| DCC5189 | Toldimfos Sodium | Stimulator of metabolism, preventing diseases associated with parturition and peri-partum period, developmental and nutritional disorders in young animals, and bone growth disorders and tetany or paresis caused by calcium, magnesium, and phosphorus metabo |
|
| DCC5190 | Tonantzitlolone | Natural agonist of TPRC1/4/5 channels, also acting as a dual PKCα and PKCθ activator, inducing an insulin resistant phenotype by inhibiting IRS1 and the PI3K/Akt pathway, activating the heat shock factor 1 (HSF1) transcription factor driving glucose depen |
|
| DCC5191 | Top1/tdp1-in-c12 | Novel dual TOP1 and TDP1 inhibitor, inducing both cellular TOP1cc, TDP1cc formation and DNA damage, resulting in cancer cell apoptosis at a sub-micromolar concentration |
|
| DCC5192 | Top1210 | Novel narrow spectrum kinase inhibitor, potently inhibiting P38a, Src, and Syk kinase activities |
|
| DCC5193 | Top-dnj | Novel Selective Inhibitor of Endoplasmic Reticulum α-Glucosidase II, Exhibiting Antiflaviviral Activity |
|
| DCC5194 | Topki-nbd | Novel highly specific fluorescent TOPK inhibitor |
|
| DCC5195 | To-pro3 Iodide | Nucleic acid stain, acting on viable, early apoptotic and necrotic cells differentially, showing specific staining of nuclei without any staining of the cytoplasm |
|
| DCC5196 | Tortuosamine | Natural psychoactive agent |
|
| DCC5197 | Tos-gly-pro-arg-anba-ipa | Chromogenic peptide substrate for the rapid and specific photometric assay of recombinant hirudin (r-hirudin) |
|
| DCC5198 | Tosylaniline | Selective CA IX inhibitor |
|
| DCC5199 | Toxt-in-8 | Novel ToxT inhibitor, reducing Vibrio cholerae virulence in vivo and effectively inhibiting intestinal colonization in the infant mouse |
|
| DCC5200 | Tp-008 | Novel probe for activin receptor-like kinase (ALK4 and ALK5) |
|
| DCC5201 | Tp-040 | Novel inhibitor of O-GlcNAcase (OGA) |
|
| DCC5202 | Tp-238 Hydrochloride | Novel probe for CECR2/BPTF bromodomains |
|
| DCC5203 | Tpe-gal | First-in-class fluorescent drug delivery vesicle that can efficiently load both water-soluble and -insoluble anticancer drugs |
|
| DCC5204 | Tph1-in-23a | Novel Peripheral Selective Tryptophan Hydroxylase 1 (TPH1) Inhibitor (IC 50 : 42nM) for Obesity and Fatty Liver Disease |
|
| DCC5205 | Tpi1609-10 | Inhibitor of tyrosine recombinases and Holliday junction-resolving enzymes; Antibacterial |
|
| DCC5206 | Tpi-1917-49 | Promising amyloid reducing agent by lowering the levels of Aβ. |
|
| DCC5207 | Tpi-2659-17 | Novel Specific Inhibitor of Type I Collagen Production in Fibrosis |
|
| DCC5208 | Tpi-287 | Novel taxane family member, reducing the brain metastatic colonization of breast cancer cells |
|
| DCC5209 | Tpl2-in-i | Novel tumour progression locus 2 (Tpl2) kinase inhibitor |
|
| DCC5210 | Tpmp-i-2 | Enhancer of the cytotoxic effect of immunotoxins (ITs) which results in increased apoptosis in different cancer cells |
|
| DCC5211 | Tpp-cl2 | Mitochondria-activatable luciferin (MAL-Probe) |
|
| DCC5212 | Tp-s1-68 | Novel Type-I Inhibitor of TIE-2 |
|
| DCC5213 | Tracizoline | Potent I 2 -imidazoline receptor agonist |
|
| DCC5214 | Trans- Resveratrol-4’-sulfate Sodium Salt | Metabolite of Resveratrol |
|
| DCC5215 | Trans-abcd | Potent and selective NMDA agonist |
|
| DCC5216 | Trans-bopc1 | Novel HuR binder, modulating HuR-RNA interactions |
|
| DCC5217 | Trans-cbtbp | Novel KGA allosteric inhibitor |
|
